Delphine Corseaux

Title: Delphine Corseaux: Innovator in Aortic Valve Calcification Research

Introduction

Delphine Corseaux is a prominent inventor based in Lille, France. She has made significant contributions to the field of cardiovascular health, particularly in understanding and addressing aortic valve calcification. Her innovative research has led to the development of a patent that holds promise for improving heart health.

Latest Patents

Delphine Corseaux holds a patent for the "Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve." Aortic valve calcification is a condition characterized by calcium deposits forming on the aortic valve in the heart. These deposits can lead to narrowing of the valve opening, resulting in a condition known as aortic valve stenosis. Her research demonstrates that retinoic acid can decrease calcification and the osteoblast-like phenotype in valvular interstitial cells (VICs). More specifically, RARα activation has been shown to reduce calcification and the osteoblast-like phenotype in VICs. Conversely, inhibiting ALDH1A1 increases calcification and the osteoblast-like phenotype in VICs. These findings suggest that RAR agonists could be effective in reversing, preventing, or delaying aortic valve calcification.

Career Highlights

Throughout her career, Delphine has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Lille. Her work has been pivotal in advancing the understanding of cardiovascular diseases and potential therapeutic approaches.

Collaborations

Delphine has collaborated with notable colleagues, including Sophie Susen and Yoann Sottejeau. These partnerships have enriched her research and contributed to the development of innovative solutions in her field.

Conclusion

Delphine Corseaux is a trailblazer in the research of aortic valve calcification, with a patent that could significantly impact cardiovascular health. Her dedication to innovation and collaboration continues to drive advancements in medical science.